000 | 01789 a2200625 4500 | ||
---|---|---|---|
005 | 20250513202605.0 | ||
264 | 0 | _c20000218 | |
008 | 200002s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.54.2.438 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDodel, R C | |
245 | 0 | 0 |
_aAlpha2 macroglobulin and the risk of Alzheimer's disease. _h[electronic resource] |
260 |
_bNeurology _cJan 2000 |
||
300 |
_a438-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlzheimer Disease _xepidemiology |
650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
650 | 0 | 4 | _aExons |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aalpha-Macroglobulins _xgenetics |
700 | 1 | _aDu, Y | |
700 | 1 | _aBales, K R | |
700 | 1 | _aGao, F | |
700 | 1 | _aEastwood, B | |
700 | 1 | _aGlazier, B | |
700 | 1 | _aZimmer, R | |
700 | 1 | _aCordell, B | |
700 | 1 | _aHake, A | |
700 | 1 | _aEvans, R | |
700 | 1 | _aGallagher-Thompson, D | |
700 | 1 | _aThompson, L W | |
700 | 1 | _aTinklenberg, J R | |
700 | 1 | _aPfefferbaum, A | |
700 | 1 | _aSullivan, E V | |
700 | 1 | _aYesavage, J | |
700 | 1 | _aAlstiel, L | |
700 | 1 | _aGasser, T | |
700 | 1 | _aFarlow, M R | |
700 | 1 | _aMurphy, G M | |
700 | 1 | _aPaul, S M | |
773 | 0 |
_tNeurology _gvol. 54 _gno. 2 _gp. 438-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.54.2.438 _zAvailable from publisher's website |
999 |
_c10623151 _d10623151 |